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Pregledni ~lanak
COMPLEXITY OF FREE RADICAL METABOLISM IN HUMAN ERYTHROCYTES
KOMPLEKSNOST METABOLIZMA SLOBODNIH RADIKALA U HUMANIM ERITROCITIMA
Aleksandra Nikoli}-Koki}, Du{ko Blagojevi}, Mihajlo B. Spasi}
University of Belgrade, Institute for Biological Research »Sini{a Stankovi}«, Department of Physiology
Kratak sadr`aj: Produkcija slobodnih radikala u eritroci -
tima uglavnom se odnosi na nastajanje superoksid anjon
radikala (O2
.–) putem autooksidacije oksihemoglobina u
methemoglobin. Ljudski eritrociti izlo`eni su prooksidacio -
nom delovanju vodonik-peroksida nastalog dismutacijom
O2
.– ili iz cirkulacije, kao i azot oksidu (NO) iz cirkulacije. Od
di rektnih reakcija slobodnih radikala, reakcija O2
.– i NO uz
nastajanje peroksinitrita je reakcija sa primarno {tetnim po -
sledicama po eritrocite. U eritrocitima se nalaze enzimi
za{tite od oksidacionih o{te}enja, kao {to su superoksid dis -
mu taza (SOD, EC 1.15.1.1), katalaza (CAT, EC 1.11.1.6),
glutation peroksidaza (GSHPx, EC 1.11.1.9) i glutation re -
duktaza (GR, EC 1.6.4.2) kao i komponente male mo lekul -
ske mase (glutation, vitamini E i C). Njihovim sadej stvom se
kanali{u reakcije slobodnih radikala tako da di rektna o{te -
}enja biomakromolekula budu {to manja. Me|u tim, kako
nema de novo sinteze enzima u maturiranim eri trocitima,
kapacitet ovih sistema je ograni~en, jer slobo d noradikalske
vrste i direktno inhibiraju neke od enzima. Promene na
enzimima i njihova inhibicija slobodnim radi kalima uti~u na
kapacitet za{tite od oksidacionih o{te}enja i relativni udeo
pojedinih komponenti u ukupnom antioksi da tivnom poten ci -
jalu. To se mo`e pratiti i preko promena aktiv nosti pojedi -
na~nih komponenti, ali i me |u sobnih odnosa izme|u kom -
ponenti antioksidativne odbrane diskrimina cio nim sta ti sti ~kim
metodama, koje ukazuju na sveukupnost i kompleksnost
odnosa antioksida tivnih kompo nenti u eritro citima i njihov
sistemski zna~aj.
Klju~ne re~i: slobodni radikali, superoksid, azot-oksid,
antioksidanti 
Introduction
The concept of an antioxidant defence system
(ADS), as a means of preventing oxidative cell damage
and promoting erythrocyte antioxidative instead of
prooxidative role in the circulation, implies balanced
activities of the erythrocyte ADS. Erythrocytes are
exposed to oxygen radicals that are continuously gene -
rated primarily due to the auto-oxidation of oxy hae -
moglobin (Hb) to methaemoglobin (1, 2). Erythrocytes
Summary: The auto-oxidation of oxyhaemoglobin to
methaemoglobin generating superoxide anion radical (O2
.–)
represents the main source of free radicals in the erythro -
cytes. Hydrogen peroxide is produced by O2
.– dismutation or
originates from the circulation. Human erythrocytes are also
exposed to the prooxidative actions of nitric oxide (NO) from
circulation. Free radicals that may induce reactions with direct
dangerous consequences to erythrocytes are also preceded
by the reaction of O2
.– and NO producing per oxynitrite. In
physiological settings, erythrocytes show a self-sustai ning
activity of antioxidative defence (AD) enzymes, such as:
superoxide dismutase (SOD, EC 1.11.16), catalase (CAT, EC
1.11.1.6), glutathione peroxidase (GSHPx, EC 1.11.1.9) and
glutathione reductase (GR, EC 1.6.4.2), as well as low
molecular weight antioxidants: glutathione and vitamins E
and C. Their coordinate actions protect the erythro cyte’s bio -
macromolecules from free radical-mediated da mage. Since
there is no de novo synthesis of AD enzymes in mature
erythrocytes, their defence capacity is limited. Free radicals
influence antioxidative enzymes capacities and relative share
of particular components in the whole anti oxidative system.
Therefore, by measuring changes in the activity of individual
AD components, as well as their inter relations by statistical
canonical discriminant methods, valuable data about the
com plexity, overall relations and coordi nated actions in the
AD system in erythrocytes and its relevance for systemic
effects can be acquired.
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are also exposed to oxidative pressure from plasma
(particularly hydrogen peroxide – H2O2 and nitric oxide
– NO). Under normal conditions erythrocytes contain
sufficient levels of scavenger enzymes such as Cu,Zn-
SOD, CAT, and selenium-dependent GSH-Px to protect
themselves from free radical injury. Cu,Zn-SOD
catalyses the dismu tation of superoxide (O2.–) to H2O2,
which is then independently converted to water by CAT
or by GSH-Px (3). It is important to note that the
activities of these enzymes in erythrocytes are higher
than in most other tissues in the body (4). In humans,
erythrocytes lack a nucleus, mitochondria and other
organelles. Hence, there is no de novo synthesis of
ADS compo nents, making it difficult to maintain ery -
throcyte membranes intact for a long period – 120
days. A comprehensive understanding of the ADS
should be based on the knowledge of activities and
mutual interactions of the enzymes involved in free
radical detoxication (5). Balan ced action of antioxidant
components is neces sary for ROS homeostasis and
appropriate redox state. Furthermore, if there is any
coordinated action bet ween the components, there
might be a statistically signif icant correlation (positive
and negative) between them. Therefore, changes in
the activity of some antioxidant component should be
accompanied by changes in other antioxidative
enzymes in a correlated manner. Since correlation
analysis calculates the relations between individual
compo nents, one can perform an alternative statistical
test: canonical discriminant analysis, which calculates
differences between groups taking into consideration
the complete correlation matrix (i.e. composition of
antioxidant defence) of separate groups. The ADS in
human erythrocytes with preserved homeostasis finely
retunes its composition according to plasma oxidative
demands. An increase in the level of a specific plasma
lipid component may potentiate mem brane lipid
peroxidation in erythrocytes and decrease intra-
erythrocyte production of O2.–, which could result in a
negative correlation between SOD and GSH-Px
activities found in some experiments (6–9). The
discovery of the haemoglobin-cholesterol (Hb-Ch)
complex implies the way in which cholesterol may influ -
ence the organisation of ADS in erythrocytes (7).
Physiologically active molecules (such as nitric
oxide (NO
.
) can also react with ROS. The reaction
between O2.– and NO naturally occurs in cells pro -
ducing peroxynitrite (ONOO–) which is considered to
be a cytotoxic molecule. The production of so-called
reactive nitrogen species (RNS) represents a conse -
quence of ONOO– formation. RNS provokes nitrosa -
tive modifications of molecules and can induce nitro -
sative stress (10). The interactions of ROS and RNS
with antioxidative enzymes leading to the inhibition of
their activities, represent the primary cause of disturbed
correlations between their activities in erythrocytes. If
ROS production overwhelms the ADS, oxidative stress
occurs leading to oxidative damages. Non-specific
inter actions of ROS with different classes of intra -
cellular molecules induce oxidative damage leading to
the impairment of cellular homeostasis. As accurate
detection of in vivo ROS concentrations is still pro -
blematic, changes in the ADS may serve as a good
indicator of processes within the organism, as it res -
ponds to ROS production, changes of the environment
(as low environmental temperature) (11) and patho -
logical conditions (9). It should be stressed that the
ADS is species- and tissue-specific (12) and that anti -
oxidative enzymes in erythrocytes and the do minant
source of ROS in erythrocytes are in many aspects
quite different in comparison with extracellular fluids
and other tissues. 
Antioxidative enzymes in erythrocytes
Human erythrocytes are the most abundant and
one of the most specialized cells in the body. The main
function of erythrocytes is the transport of oxygen (O2)
and mediation of carbon dioxide (CO2) production
(13). As the red blood cell emerges from the bone
marrow, it loses its nucleus, ribosomes, and mito chon -
dria, and therefore the capacity for cell division, protein
synthesis, and mitochondrial-based oxidative reactions
(13, 14). As a consequence of their physiologic role,
erythrocytes are exposed to continuous oxidative stress.
Although oxidative stress may damage the red cell
itself, the mass effect of large quantities of ROS leaving
the red cell could have a tremendous potential to
damage other components of the circulation (15), and
vice versa. 
Normal erythrocytes have been shown to have a
reducing capacity that is 250 times greater than their
oxidizing potential (16). However, in some pathological
conditions, the erythrocyte ADS seems to be insuf fi -
cient (17, 18). Erythrocytes contain a significant quan -
tity of CuZn SOD, which keeps intra-erythrocyte O2.–
levels at concentrations as low as 10–13 mol/L. The
GSH dependent enzymes (GSHPx and GR) are also
normally present, enabling removal of H2O2 by oxi da -
tion/redu ction of GSH. No manganase superoxide
dismutase (MnSOD) is present, as there are no mito -
chondria in erythrocytes. 
Erythrocytes can act as sinks for extracellular
H2O2 (freely crosses membranes) and O2.– as it can
enter the cells via anion channels. These channels have
different functions: anchoring the cytoskeleton and
exchanging HCO3– for Cl–. However, O2.– and NO2–,
as well as the very toxic ONOO- can also enter
erythrocytes through these channels. Once inside the
cell, ONOO– reacts with GSH and oxyhaemoglobin,
yielding NO3–, methaemoglobin, some H2O2 (via O2.–
dismutation), and some ferrylhaemoglobin. 
Unfortunately, erythrocytes are particularly vulne -
rable to oxidative stress due to constant exposure to
endogenosly (autooxidation of haemoglobine-Hb) and
exogenously generated radicals (H2O2 and NO
.
from
plasma). As well as other erythrocyte compo nents,
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antioxidative enzymes are exposed to the pro oxi dative
pressure of O2.–, H2O2, ONOO–. In the reaction with
different radicals, antioxidant enzymes may lose their
primary activity and gain prooxidative properties, which
can lead to enhanced oxidative pressure and gene -
ralised oxidative stress in the whole body. 
Inhibition of antioxidant enzymes 
The examination of AD enzyme activities in vitro
has shown that CuZn-SOD possesses a constant spe -
cific activity (activity per mg of purified enzyme) and
may be inhibited irreversibly by CN- or reversibily by
H2O2 or by copper chelators such as DDC (diet hyl -
dithio car bamate) (19). Multiple electroforetic profiles
of CuZn-SOD de velop as a consequence of the
enzyme aging (20). Hydrogen peroxide, or rather its
conjugate base (OH2–), reacts with CuZnSOD,
reducing Cu(II) to Cu(I), followed by the reaction of
Cu(I) with a second hydrogen peroxide. This leads to
the oxidation of the active site, putatively described as
copper-bound hydroxyl radical (21). This, in turn, leads
to the inacti vation of enzyme through 2-oxohistidine
formation (22) and to the oxidation of various sub -
strates in the enzyme’s behaviour known as the
»peroxidative« activity of CuZn-SOD (21–24). DDC is
known to be a potent Cu chelating agent and is one of
the most widely used SOD inhibitors both in vivo and in
vitro (25-28). The mechanism of DDC-mediated
CuZn-SOD inhi bition has been described (29). DDC-
mediated SOD1 inhibition could serve as a screen for
oxidatively damaged SOD 1 protein in the blood of
acute myo cardial infarction subjects. Oxidative
inactivation of red cell SOD by its product H2O2
generates a modified protein which is recognised and
selectively degraded by an intracellular proteolytic
pathway (30). Both the loss of SOD activity and
modified binding of copper by the active site appear to
precede proteolytic recognition and degradation. The
selective degradation of H2O2–modified SOD in red
cell extracts is now seen to be catalysed by an ATP-
independent proteolytic pathway. Oxidised histidine
118 to 2-oxo histidine is generated at the active site of
CuZn-SOD exposed to H2O2 (22). An increased
concentration of H2O2 allows the pro duction of
hydroxyl radicals, especially in the presence of
catalytically-active metals (23, 31). 
Oxidatively damaged SOD may cause further
increase in free radicals due to more solvent exposed
Cu+. Such a situation is presented in Figure 1. Elec tron
paramagnetic resonance spectra of SOD inhibited with
H2O2 show that 60 minutes after the application of
H2O2, oxidatively damaged SOD cata lyse the Fenton
reaction and promote the generation of hydroxyl
radicals.
Similarly to CuZn-SOD, other antioxidative en -
zymes can also be changed or inactivated by reactive
oxygen species. Pigeolet et al. (32) tested the effect of
H2O2, cumene hydroperoxide, t-butyl hydroperoxide
and OH
.
and O2.– on GSH-Px, CuZn SOD and CAT.
The activity of GSH-Px was decreased by 50%
inactivation in the presence of hydrogen peroxide (0.1
M), cumene hydroperoxide (3x10–4 mmol/L), and t-
butyl hydroperoxide (5x10–5 mol/L). Unlike OH
.
, O2.–
did not inactivate this enzyme. CAT was inactivated by
NO, OH
.
and by O2.– but organic peroxides had no
effect. Similar to our results, Pigeolet showed a 50%
SOD inhibition with 4 x 10–4 mmol/L H2O2 (32). 
Clearly, the ADS is affected by an imbalance bet -
ween the production of reactive oxygen species and
their decomposition, which leads to new ADS settings.
Our scientific research has been directed towards
finding a cross-relation between the ADS profile of
easily accessible human material such as erythrocytes,
and the prooxidative changes at the primary site of
radical generation in other tissues. In other words, how
a chan ged ADS composition implicates the redox
processes in pathological conditions. To answer the
above questions, we applied the mathematical model
of canonical discri minated analysis to ADS changes
measured in the erythro cytes of patients with three
different diseases: cardio vascular (AIM), neurological
(ALS) and psychiatric (SCH).
Acute myocardial infarction (AMI) 
A disturbed balance between the production of
both reactive oxygen and nitrogen species and their
elimination as a consequence of acute myocardial
infarction (AMI) has been postulated to represent the
molecular basis of oxidative stress and damage which
are important factors in reperfusion injury (33). During
myocardial reperfusion injury the production of reac -
tive oxygen species arises via several routes including
mitochondrial respiratory-chain enzymes, xanthine
oxidase, and non-phagocytic and neutrophil NADPH
oxidase (34). An additional source of reactive oxygen
species during heart failure may be angiotensin II and
catecholamines (more precisely, the auto-oxidation of
catecholamines), whose increased levels represent a
consequence of sympathetic activation. An excess of
H2O2 and NO in extracellular medium is followed by
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Figure 1 Electron paramagnetic resonance spectra of
hydro xyl radicals ‘trapped’ with a DEPMPO spin-trap in the
system composed of CuZn-SOD and hydrogen peroxide 
(5 mmol/L). In the min lane it is evident that an intensive
Fenton reaction occurs.
the rise of intracellular level due to the fact that these
species can permeate through biological membranes.
H2O2 and NO may affect the ADS by inhibiting CuZn-
SOD (20) and CAT (35). This results in conditions that
propagate reperfusion injury via oxidative changes in
erythrocytes related to the shift of enzyme behavior
from antioxidant to prooxidant. Tsao and colleagues
have shown that endothelial cells lose their function
2.5 min after reperfusion injury by a mechanism
implicating reactive oxygen species formation (36).
Mitochondria in an ischemic heart may additionally
increase the generation of hydrogen peroxide during
reperfusion (37). Hydrogen peroxide may diffuse from
myocytes into the bloodstream to affect erythrocyte
function. 
Presented settings imply strong correlation
between the ADS of erythrocytes and oxidative
conditions in the heart and vessels. However, in some
patho phy siologies this may not be the case. During
reperfusion induced by streptokinase treatment, no
significant correlations between the antioxidant
defence enzyme activities were apparent (38), while in
the control popu lation we found a significant positive
correlation bet ween the activities of CAT and GSH-Px in
erythrocytes (38, 39). This indicated that ischa emia/
reper fu sion had disturbed the coordinated action of AD
enzy mes in the erythrocytes of AIM patients. Only after
sustained carvedilol therapy (168 hours duration) a
significant correlation between CuZnSOD and CAT was
found, indicating that carvedilol therapy had a positive
effect on re-establishing the normal relatio nship bet -
ween antioxidant setup in the erythrocytes and heart.
This is supported by the results of the two-way ANOVA
that showed a significant effect of treatment (38).
Amyotrophic lateral sclerosis (ALS) –
a fatal progressive disorder 
Amyotrophic lateral sclerosis (ALS), often called
motor neuron disease (MND), is an adult-onset neuro -
degenerative disease characterised by progressive
injury and death of lower motor neurons in the spinal
cord and brainstem, and upper motor neurons in the
motor cortex (40). The primary cause of disease is
unknown, and the mechanism of motor neuron injury
is complex and incompletely understood. In 1993
Rosen and co-workers found that 20% of familial MND
cases (5–10% of all cases are familial) are caused by
mutations in copper/zinc superoxide dismutase (41).
Since that time several hypothetical mechanisms have
been predicted: oxidative stress, excitotoxicity caused
by aber rant glutamate signaling, mitochondrial dysfun -
c tion, disruption of the neurofilament network and
intra ce lular trafficking along neurofilament aggre -
gation of proteins, and the involvement of non-
neuronal cells in the vicinity of motor neurons. Events
in these mecha nisms culminate in a caspase-de -
pendent programmed cell death pathway resembling
apoptosis (42). Recent findings corroborated the
hypothesis that glutamate-mediated NO overpro -
duction plays an important role in the pathogenesis of
ALS (43). Due to their ability to permeate through
biological membranes, an excess of NO and H2O2
may be present in the surrounding media of motor
neurones (44). Some data suggest that the ADS
activity is altered in erythrocytes from ALS patients (45,
46) before and after adjuvant ALS therapy (47).
Antioxidative defense enzymes in erythrocytes are
capable of detoxifying reactive oxygen species (pro -
duced endogenously or exogenously), but as men ti -
oned in the preceding sections, the enzy mes may be
structurally modified and inactivated by reactive oxygen
and nitrogen species. Both balanced and coordinated
ADS activities are of the utmost impor tance for their
correct physiological function.
In the erythocytes of SALS patients a significant
nega tive correlation between GSH-Px and CAT was
found (39). However, in FALS patients (with mutated
SOD) and healthy subjects with mutations in the SOD
molecule, no significant correlations were found
(unpublished data). These mean that the basic rela -
tion ships between the ADS components in ALS are
different and depend on systemic conditions, i.e. the
amount of produced ROS and RNS.
Using the canonical discriminant analysis, it is
possible to discriminate different categories (in this
study, the analysed groups) according to the com po -
sition of the antioxidative defense components, and to
determine which component significantly contributes
to this difference (48, 49). In this way the antioxidative
erythrocyte enzymes in SALS, FALS patients, asympto -
matic carriers and controls were analyzed by two-way
ANOVA and canonical discriminant analyses. The
results obtained showed that all examined AOS
enzymes significantly contributed to the difference in
antioxidative defense composition observed between
the groups (Figure 2). 
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Figure 2 Two-dimensional discriminant analysis showing dif -
ferences in the ADS activities in erythrocytes from SALS (–/+),
from FALS (+/+), from asymptomatic carriers of SOD1
(Leu144Phe mutation) (+/–) and from the control group (–/–).
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Schizophrenia 
Recent findings suggest that multiple neurotran s -
mitter systems may be faulty in schizophrenic patients
(50). Metabolic products of such a non-functional
system, such as H2O2 and RNS, may inhibit erythro -
cyte AD enzymes. From the initial studies of anti -
oxidative defence in schizophrenia (Sch.) (51) to the
most recent one (52), disturbed balance in the activity
of antioxidant defence enzymes in the erythrocytes of
schizophrenics was found. In never-medicated first-
episode psychotic patients, lower levels of SOD activity
were reported, but no change was observed in the
activities of CAT and GSH-Px (53). According to our
findings, it appears that schizophrenia creates con di -
tions that increase the level of H2O2 affecting circu -
lating cells. 
Our idea in examining the ADS erythrocyte
enzymes in Sch patients was to investigate whether
systemic oxidative misbalance reflects on the compo -
sition of the ADS iof erythrocytes from Sch type I (Sch
I) and type II (Sch II) patients. The correlation analysis
of antioxidant defence enzymes showed a significant
negative correla tion between GSH-Px and CAT
activities in patients with Sch I. In patients with Sch II,
GSH-Px activity showed a statistically significant
positive correlation with GR. Canonical discriminant
analysis distinguished Sch I and Sch II patients from
the controls, and among each other, with a high
degree of certainty, according to the overall group
composition of AD enzymes (Figure 3) (54). The results
indicated a difference in the compo sition of ADS
between controls and antipsychotic treated Sch I and
Sch II patients, with a possible negative feedback in -
fluence on the pathological process, and may represent
a rationale for applying antioxidants in Sch therapy.
According to our findings, it appears that schizo -
phrenia creates conditions that increase the level of
hydrogen peroxide, affecting circulating cells. The
source of H2O2 in the circulation may be an increased
monoamine oxidase activity, since an increased
turnover rate of catecholamines was found in schizo -
phrenic patients. Such changes in the circulation may
shift ery throcyte role from antioxidative to pro oxidative.
Presumably the best way to address these negative
effects is through controlling oxidative stress in a
physiological manner, not aiming only at the level of
antioxidants, but rather at their interactions. According
to Crow (55), Sch I and Sch II show different patho -
genetic mechanisms which result in differences in the
therapeutic response to antipsychotics. Crow wrote that
there were two syndromes, due to different patho phy -
siological processes: Sch I with changes in dopamine
transmission and Sch II with encephalopathy (55). Our
results on ADS changes seem to confirm such a
statement.
Conclusion
We first used antioxidative defence enzyme
relations as a possible bioindicator of the effects of
ionizing radiation (56). Since then the concept that the
oxidative status of various tissues may be determined
by studying the antioxidant defence system has been
verified in several papers. Erythrocytes are particularly
vulnerable to oxidative stress because they are exposed
to oxygen radicals, that are continuously generated
primarily due to the auto-oxidation of haemoglobin
(Hb). There is a defence system against oxidative stress
in erythrocytes composed of CuZn-SOD, CAT, sele -
nium-dependent GSH-Px, and GR. Erythrocytes are
also exposed to oxidative pressure from plasma (parti -
cularly mediated by H2O2 and NO). The measure ments
of changes in the activities of individual antio xi dative
defence components as well as their inter relations,
using statistical cannonical discriminant methods, are
capable of providing a valuable insight into the
complexity of overall relations, coordinated actions in
the antioxidative defense system in erythrocytes and its
relevance to systemic effects.
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Figure 3 Two-dimensional discriminant analysis showing
differences in the activities of antioxidant defense enzymes in
the erythrocytes of controls, Sch I and Sch II. 
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